Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Multimodality Therapy in Mantle Cell Lymphoma
NCT00004231Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Aug 2006
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, doxorubicin, teniposide, prednisone, vincristine in mantle cell lymphoma (MCL), sponsored by Northwestern University. Started Oct 1999; status: completed.
02
Drugs
cyclophosphamidedoxorubicinteniposideprednisonevincristine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00004231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004231.